帕利哌酮中毒后2.5年仍可测得血浆浓度:一例病例报告
本文报告一例长效注射用帕利哌酮棕榈酸酯中毒病例,患者出现深度镇静和肌张力障碍,血浆帕利哌酮浓度接近参考范围上限的五倍。尝试用圣约翰草诱导P-糖蛋白以增加清除,但效果有限。停药2.5年后血浆帕利哌酮仍处于治疗范围低值,且患者仍有锥体外系症状。
要点
- 长效帕利哌酮注射后中毒可致深度镇静和肌张力障碍。
- 圣约翰草诱导P-糖蛋白对帕利哌酮清除效果有限。
- 停药2.5年后仍可测得帕利哌酮血浆浓度并伴锥体外系症状。
核心结论
- 帕利哌酮棕榈酸酯中毒可导致深度镇静和肌张力障碍,且停药2.5年后血浆仍可测得药物浓度并伴锥体外系症状。
研究设计与样本
- 单例病例报告,患者接受长效肌注帕利哌酮治疗多年,末次注射后8天入院。
主要发现
- 患者入院时血浆帕利哌酮浓度接近参考范围上限的五倍。
- 使用圣约翰草诱导P-糖蛋白对帕利哌酮清除效果有限。
- 血浆浓度和肌张力障碍随时间下降。
- 停药2.5年后血浆帕利哌酮浓度处于正常治疗范围低值,患者仍有锥体外系症状。
临床怎么用
- 临床应警惕长效帕利哌酮注射剂过量或中毒的迟发效应。
- 对帕利哌酮中毒患者需长期监测血浆浓度和锥体外系症状。
局限性
- 为单例病例报告,结果外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
We report a poisoning with paliperidone palmitate, a once-monthly, long-acting injectable antipsychotic. The patient suffered from deep sedation and dystonia. She had been treated with extended release intramuscular paliperidone for several years and had received her last injection 8 days prior to admission. The plasma paliperidone was nearly five times higher than the upper reference range. Paliperidone is a substrate of p-glycoprotein and we therefore aimed to increase its elimination by inducing p-glycoprotein through treatment with St John's wort. This seemed to have a limited effect on paliperidone clearance. Plasma concentration levels decreased with time as did the dystonia. All antipsychotic treatment was discontinued after this unfortunate event, and the patient did specifically not receive any prescriptions of paliperidone or risperidone. However, the plasma paliperidone concentration was in the low end of the normal therapeutic range 2.5 years after the last dose of paliperidone was administered, and the patient still had some extrapyramidal symptoms.
引用
- Nersesjan M, Wagner M, Dalhoff KP, et al. Paliperidone poisoning and measurable plasma concentrations 2.5 years after last administered dose: A case report. Br J Clin Pharmacol. 2024. PMID: 38450747. doi:10.1111/bcp.16036
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。